Home/Filings/4/0001209191-23-048814
4//SEC Filing

Sullivan Lara 4

Accession 0001209191-23-048814

CIK 0001782223other

Filed

Sep 7, 8:00 PM ET

Accepted

Sep 8, 5:00 PM ET

Size

4.7 KB

Accession

0001209191-23-048814

Insider Transaction Report

Form 4
Period: 2023-09-07
Sullivan Lara
DirectorPresident ,CEO & CMO
Transactions
  • Award

    Common Stock

    2023-09-07+469,4832,625,182 total
Footnotes (1)
  • [F1]Represents restricted stock units that are fully vested.

Issuer

Pyxis Oncology, Inc.

CIK 0001782223

Entity typeother

Related Parties

1
  • filerCIK 0001769457

Filing Metadata

Form type
4
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 5:00 PM ET
Size
4.7 KB